GFAP Degradation in TBI: Linking Novel Modified Products to Astrocyte Pathology and Patient Outcome
Ina B. Wanner, Julia Halford, Jonathan Lopez, Sean Shen, Yu Chen, Hayden Zhao, Carolina Salas, Rachel R. Ogorzalek Loo, Steven A. Robicsek, Benjamin M. Ellingson, JEFFREY A. GORNBEIN, Timothy E. Van Meter, Gerry Shaw, Joseph A. Loo, Paul M Vespa
This study identifies novel GFAP breakdown products and modifications in TBI patients, linking them to astrocyte pathology and clinical outcomes.
Acta Neuropathologica Communications · Apr 24, 2026Peer-reviewedNeuroscience